Skip to content

Life Sciences

RABS or Isolator: Choosing Barrier Technology

  • Life Sciences
  • 2 min read

EU GMP Annex 1 pushed barrier technology from optional to expected for aseptic processing, and the question most projects now face is not whether to use a barrier but which one. The honest answer is that neither is better; they fail differently and cost differently, and the process decides.

What each one is

A RABS — Restricted Access Barrier System — is a rigid enclosure with unidirectional airflow over the critical zone, operated through glove ports, sitting inside a Grade B background. Open-door interventions are possible under a defined procedure, at the cost of a documented line clearance.

An isolator is sealed, has its own air handling and pressure regime, and is bio-decontaminated as a unit, usually with vaporized hydrogen peroxide (VHP). Because the separation is physical and validated, the background can be a lower grade — commonly Grade C or even D.

The number that decides it

Intervention frequency. An isolator gives higher sterility assurance and a far cheaper background, but every entry costs a bio-decontamination cycle measured in hours. A process that runs long campaigns with few interventions suits it perfectly. A process with frequent format changes, short batches or regular manual intervention will spend more time decontaminating than producing.

A RABS accepts interventions more readily and pays for that flexibility every hour of every day, by requiring a Grade B background — which means the air handling, the gowning, the environmental monitoring and the personnel cost of Grade B for the life of the facility.

What the comparison usually misses

Background running cost is the dominant lifetime figure. Grade B is expensive continuously. Over ten years the difference between a Grade B and a Grade C background will often exceed the capital difference between the two barrier options, and it rarely appears in the capital comparison that decides the project.

Glove management is a program, not a task. Gloves are the most common breach point in either system. Integrity testing frequency, replacement intervals and the change procedure need to be designed with the barrier, and they are a recurring operational load.

Decontamination cycle development takes longer than expected. An isolator's VHP cycle has to be developed and validated against load configuration and materials. It is a project in itself and is routinely underestimated in the project schedule.

Material transfer decides the layout. How components enter and product leaves — rapid transfer ports, a docked autoclave or depyrogenation tunnel, or a defined pass-through — shapes the room around the barrier. Deciding it late means moving walls.

How to choose

Map the interventions first: every one the process needs, how often, and how long each takes. Then price the background over the facility's expected life, not the capital cost of the enclosure. The answer usually becomes obvious, and it is frequently not the one the initial capital comparison suggested.

Industries

Related

More on this subject

The 95% UCL left ISO 14644-1 in 2015

The 1999 edition of ISO 14644-1 asked for a 95% upper confidence limit when a room had two to nine sampling locations. The 2015 edition removed it: the number of locations comes from Table A.1 and each location's average has to meet the class limit. Protocols that still carry the formula mix two methods.

InsightRead

WFI belongs in the Contamination Control Strategy

EU GMP Annex 1 (2022) gives WFI circulation above 70 °C as an example of minimizing the risk of microbial growth. Keeping a loop hot drives the design: ASME BPE dead legs of L/D ≤ 2, turbulent flow to the last user point, planned sanitization and sensors on the return. The CCS should justify all of it.

InsightRead